Suppr超能文献

SARS-CoV-2 感染与在人体和尸检大脑中的持续存在。

SARS-CoV-2 infection and persistence in the human body and brain at autopsy.

机构信息

Emerging Pathogens Section, Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA.

Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

出版信息

Nature. 2022 Dec;612(7941):758-763. doi: 10.1038/s41586-022-05542-y. Epub 2022 Dec 14.

Abstract

Coronavirus disease 2019 (COVID-19) is known to cause multi-organ dysfunction during acute infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), with some patients experiencing prolonged symptoms, termed post-acute sequelae of SARS-CoV-2 (refs. ). However, the burden of infection outside the respiratory tract and time to viral clearance are not well characterized, particularly in the brain. Here we carried out complete autopsies on 44 patients who died with COVID-19, with extensive sampling of the central nervous system in 11 of these patients, to map and quantify the distribution, replication and cell-type specificity of SARS-CoV-2 across the human body, including the brain, from acute infection to more than seven months following symptom onset. We show that SARS-CoV-2 is widely distributed, predominantly among patients who died with severe COVID-19, and that virus replication is present in multiple respiratory and non-respiratory tissues, including the brain, early in infection. Further, we detected persistent SARS-CoV-2 RNA in multiple anatomic sites, including throughout the brain, as late as 230 days following symptom onset in one case. Despite extensive distribution of SARS-CoV-2 RNA throughout the body, we observed little evidence of inflammation or direct viral cytopathology outside the respiratory tract. Our data indicate that in some patients SARS-CoV-2 can cause systemic infection and persist in the body for months.

摘要

新型冠状病毒病(COVID-19)已知会在严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)急性感染期间导致多器官功能障碍,一些患者会出现长期症状,称为 SARS-CoV-2 后急性后遗症(post-acute sequelae of SARS-CoV-2,PA-SARS-CoV-2)。然而,呼吸道以外的感染负担和病毒清除时间尚不清楚,特别是在大脑中。在这里,我们对 44 名死于 COVID-19 的患者进行了完整的尸检,并对其中 11 名患者的中枢神经系统进行了广泛采样,以绘制和量化 SARS-CoV-2 在人体中的分布、复制和细胞类型特异性,包括大脑,从急性感染到症状出现后七个多月。我们表明 SARS-CoV-2 广泛分布,主要存在于死于严重 COVID-19 的患者中,病毒复制存在于多种呼吸道和非呼吸道组织中,包括大脑,在感染早期。此外,我们在多个解剖部位检测到持续存在的 SARS-CoV-2 RNA,包括在一个病例中,在症状出现后 230 天,大脑各处均存在 SARS-CoV-2 RNA。尽管 SARS-CoV-2 RNA 在全身广泛分布,但我们在外呼吸道以外观察到很少有炎症或直接病毒细胞病理学的证据。我们的数据表明,在一些患者中,SARS-CoV-2 可能会导致全身感染并在体内持续数月。

相似文献

1
SARS-CoV-2 infection and persistence in the human body and brain at autopsy.
Nature. 2022 Dec;612(7941):758-763. doi: 10.1038/s41586-022-05542-y. Epub 2022 Dec 14.
3
Intrinsic factors behind long COVID: III. Persistence of SARS-CoV-2 and its components.
J Cell Biochem. 2024 Jan;125(1):22-44. doi: 10.1002/jcb.30514. Epub 2023 Dec 14.
7
Characterisation of cardiac pathology in 23 autopsies of lethal COVID-19.
J Pathol Clin Res. 2021 Jul;7(4):326-337. doi: 10.1002/cjp2.212. Epub 2021 Apr 9.
9
In situ detection of SARS-CoV-2 in lungs and airways of patients with COVID-19.
Mod Pathol. 2020 Nov;33(11):2104-2114. doi: 10.1038/s41379-020-0595-z. Epub 2020 Jun 19.

引用本文的文献

2
Successful treatment of PGAD/GPD with leuprolide: a case report.
Front Psychiatry. 2025 Aug 5;16:1623256. doi: 10.3389/fpsyt.2025.1623256. eCollection 2025.
4
What Long COVID investigators can learn from four decades of ME/CFS research.
Brain Behav Immun Integr. 2023 Dec;4. doi: 10.1016/j.bbii.2023.100022. Epub 2023 Sep 7.
6
Aggregation potency and proinflammatory effects of SARS-CoV-2 proteins.
Sci Rep. 2025 Aug 4;15(1):28446. doi: 10.1038/s41598-025-10013-1.
7
White matter changes in recovered COVID-19 patients: insights from DTI, DKI, and NODDI metrics.
Front Neurol. 2025 Jul 18;16:1580262. doi: 10.3389/fneur.2025.1580262. eCollection 2025.

本文引用的文献

1
Innate immunity: the first line of defense against SARS-CoV-2.
Nat Immunol. 2022 Feb;23(2):165-176. doi: 10.1038/s41590-021-01091-0. Epub 2022 Feb 1.
2
Evidence of SARS-CoV-2-Specific T-Cell-Mediated Myocarditis in a MIS-A Case.
Front Immunol. 2021 Dec 9;12:779026. doi: 10.3389/fimmu.2021.779026. eCollection 2021.
3
Immune dysregulation and immunopathology induced by SARS-CoV-2 and related coronaviruses - are we our own worst enemy?
Nat Rev Immunol. 2022 Jan;22(1):47-56. doi: 10.1038/s41577-021-00656-2. Epub 2021 Nov 26.
4
Early developing B cells undergo negative selection by central nervous system-specific antigens in the meninges.
Immunity. 2021 Dec 14;54(12):2784-2794.e6. doi: 10.1016/j.immuni.2021.09.016. Epub 2021 Oct 8.
5
Mechanisms of Antiviral Immune Evasion of SARS-CoV-2.
J Mol Biol. 2022 Mar 30;434(6):167265. doi: 10.1016/j.jmb.2021.167265. Epub 2021 Sep 22.
6
Patterns of within-host genetic diversity in SARS-CoV-2.
Elife. 2021 Aug 13;10:e66857. doi: 10.7554/eLife.66857.
8
Can Testing Predict SARS-CoV-2 Infectivity? The Potential for Certain Methods To Be Surrogates for Replication-Competent Virus.
J Clin Microbiol. 2021 Oct 19;59(11):e0046921. doi: 10.1128/JCM.00469-21. Epub 2021 Aug 4.
9
Long covid-mechanisms, risk factors, and management.
BMJ. 2021 Jul 26;374:n1648. doi: 10.1136/bmj.n1648.
10
A cohort autopsy study defines COVID-19 systemic pathogenesis.
Cell Res. 2021 Aug;31(8):836-846. doi: 10.1038/s41422-021-00523-8. Epub 2021 Jun 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验